Simpler Grants.gov #PAR-25-353

NIH Solicitation for Drug and Device Discovery/Development for Mental Disorders

The National Institutes of Health (NIH) is inviting applications for the National Cooperative Drug/Device Discovery/Development Groups (NCDDG) program, aimed at advancing research and development for mental health, substance use, and alcohol use disorders. - Government Buyer: - National Institutes of Health (NIH) - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or vendors are named in this solicitation - Products/Services Requested: - Research and development of new candidate drugs, neurostimulation devices, novel ligands, and circuit-engagement devices for mental disorders, SUDs, and AUD - Preclinical development and proof of concept testing - Optional clinical trial components - No specific part numbers or quantities are provided - Unique or Notable Requirements: - Multidisciplinary, long-term research efforts are encouraged - Partnerships between academia and industry are supported - Broad eligibility: educational institutions, nonprofits, government entities, and businesses - Focus on both drug and device innovation for neuropsychiatric conditions

Description

This funding opportunity announcement (FOA) encourages applications to advance the discovery, preclinical development, and proof of concept testing of new candidate agents and neurostimulation approaches for the treatment of mental disorders, substance use disorders, or alcohol use disorder. The FOA also supports the development of novel ligands and circuit-engagement devices as tools to further characterize or validate drug/device targets. Partnerships between academia and industry are strongly encouraged, and the program supports multidisciplinary, long-term research efforts. Projects seeking support for discrete, specified projects should consider the companion U01 FOA.

View original listing